BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17285884)

  • 1. Transient myeloproliferative disorder associated with trisomy 21.
    Kruger B
    Neonatal Netw; 2007; 26(1):7-19. PubMed ID: 17285884
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
    Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
    Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down's syndrome with transient myeloproliferative disorder.
    Dhaded SM; Das R; Kumar P; Narang A
    Indian Pediatr; 1996 Nov; 33(11):964-6. PubMed ID: 9141835
    [No Abstract]   [Full Text] [Related]  

  • 4. Vesiculopustular eruption in a neonate with trisomy 21 syndrome as a clue of transient myeloproliferative disorders.
    Piersigilli F; Diociaiuti A; Boldrini R; Auriti C; Curci M; El Hachem M; Seganti G
    Cutis; 2010 Jun; 85(6):286-8. PubMed ID: 20666188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test and teach. Number Seventy. Diagnosis: Transient myeloproliferative disorder in a child with Down's syndrome.
    Wright SJ; Kerwick AM; Rodwell RL; Taylor KM
    Pathology; 1993 Apr; 25(2):133, 207-8. PubMed ID: 8367191
    [No Abstract]   [Full Text] [Related]  

  • 6. Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder.
    Gamis AS; Smith FO
    Br J Haematol; 2012 Nov; 159(3):277-87. PubMed ID: 22966823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Building trust with families in neonatal intensive care units.
    Manning J
    Nurs N Z; 2006 Jul; 12(6):18-20. PubMed ID: 16922140
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient myeloproliferative disorder causing a vesiculopustular eruption in a phenotypically normal neonate.
    Solky BA; Yang FC; Xu X; Levins P
    Pediatr Dermatol; 2004; 21(5):551-4. PubMed ID: 15461760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient myeloproliferative disease: keeping a high index of suspicion.
    King ME; Hueckel R
    J Pediatr Oncol Nurs; 2012; 29(5):289-93. PubMed ID: 22907684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine diagnosis and management of transient myeloproliferative disorder.
    Strobelt N; Ghidini A; Locatelli A; Vergani P; Mariani S; Biondi A
    Am J Perinatol; 1995 Mar; 12(2):132-4. PubMed ID: 7779196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caring for the visually impaired infant.
    Mitchell S
    Neonatal Netw; 1999 Oct; 18(7):41, 44-6. PubMed ID: 10808887
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of haptonomy in neonatal intensive care].
    Bracq C
    Rev Infirm; 2008 Mar; (138):17. PubMed ID: 18416377
    [No Abstract]   [Full Text] [Related]  

  • 13. NANN Position Statement 3047: Medication safety in the neonatal intensive care unit.
    NANN Board of Directors
    Adv Neonatal Care; 2009 Dec; 9(6):319-26. PubMed ID: 20010151
    [No Abstract]   [Full Text] [Related]  

  • 14. Midwifery basics: complications in pregnancy (3). Neonatal resuscitation.
    Baston H
    Pract Midwife; 2005 Dec; 8(11):25-7. PubMed ID: 16372601
    [No Abstract]   [Full Text] [Related]  

  • 15. NANN Position Statement 3046: The use of human milk and breastfeeding in the neonatal intensive care unit.
    NANN Board of Directors
    Adv Neonatal Care; 2009 Dec; 9(6):314-8. PubMed ID: 20010150
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transient myeloproliferative syndrome or congenital leukemia in a newborn infant with Down syndrome?].
    Maszkiewicz W; Zarczynska B; Koralewska J
    Wiad Lek; 1989 May; 42(10):685-8. PubMed ID: 2534337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parental visits and infant care: understanding parents' needs.
    Griffin T
    Neonatal Netw; 2001 Feb; 20(1):65. PubMed ID: 12143843
    [No Abstract]   [Full Text] [Related]  

  • 18. [GATA1 analysis in myeloproliferative disorders associated to trisomy 21].
    Fuster Soler JL; Norton A; Galera Miñarro A; Bermúdez Cortés M; Llinares Riestra ME; Ortuño Giner F
    An Pediatr (Barc); 2011 Jan; 74(1):31-7. PubMed ID: 20870473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal vesiculopustular eruption of the face: a sign of trisomy 21-associated transient myeloproliferative disorder.
    Moriuchi R; Shibaki A; Yasukawa K; Onozuka T; Sato T; Kaneda M; Iguchi A; Kobayashi R; Shimizu H
    Br J Dermatol; 2007 Jun; 156(6):1373-4. PubMed ID: 17459046
    [No Abstract]   [Full Text] [Related]  

  • 20. [Transient myeloproliferative disorder in a neonate without Down syndrome].
    Adam M; Vincenot A; Gouraud F; Harvel C; Perot C; Portnoi MF; Andre-Kerneis E; Giraudier S; Leverger G; Favier R
    Ann Biol Clin (Paris); 2007; 65(5):569-73. PubMed ID: 17913678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.